Literature DB >> 24146137

Reduction of the reinforcing effectiveness of cocaine by continuous D-amphetamine treatment in rats: importance of active self-administration during treatment period.

Benjamin A Zimmer1, Keri A Chiodo, David C S Roberts.   

Abstract

RATIONALE: Continuous administration of D-amphetamine has shown promise as a treatment for psychostimulant addiction. In rodent studies, constant infusion of D-amphetamine (5 mg/kg/day) has been shown to reduce cocaine-reinforced responding in the dose range of 0.19-0.75 mg/kg/inf.
OBJECTIVES: The present study tested whether these effects were a reflection of pharmacological interactions between D-amphetamine and cocaine or if they resulted from associative learning mechanisms
METHODS: After stable progressive ratio (PR) baselines were established, rats were implanted with subcutaneous osmotic minipumps filled with either D-amphetamine (5 mg/kg/day-groups 1 and 2) or saline (group 3). During the treatment period, groups 1 and 3 self-administered cocaine at a dose that was previously shown to produce the most robust effects in combination with D-amphetamine treatment (0.19 mg/kg/inf), while group 2 received passive cocaine infusions.
RESULTS: In replication of previous studies, D-amphetamine treatment resulted in a significant (35 %) decrease in breakpoints relative to saline controls. By contrast, no reductions in breakpoints were observed in animals that received passive cocaine infusions during the treatment period (group 2).
CONCLUSIONS: Active self-administration of cocaine during the treatment period appears to be an important factor in reducing cocaine-reinforced breakpoints. These findings suggest learning mechanisms are involved in the therapeutic effects of continuous D-amphetamine, and pharmacological interaction mechanisms such as cross-tolerance cannot completely account for the observed decreases in cocaine seeking.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24146137      PMCID: PMC4327829          DOI: 10.1007/s00213-013-3305-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Pharmacotherapy and other treatments for cocaine abuse and dependence.

Authors:  Frank J Vocci; Ahmed Elkashef
Journal:  Curr Opin Psychiatry       Date:  2005-05       Impact factor: 4.741

Review 2.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

Review 3.  Medications development: successes and challenges.

Authors:  Frank Vocci; Walter Ling
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

Review 4.  Medication development for addictive disorders: the state of the science.

Authors:  Frank J Vocci; Jane Acri; Ahmed Elkashef
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

5.  Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation.

Authors:  R White
Journal:  Addiction       Date:  2000-02       Impact factor: 6.526

6.  Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Authors:  Lara A Ray; Kent E Hutchison
Journal:  Arch Gen Psychiatry       Date:  2007-09

Review 7.  How to make a rat addicted to cocaine.

Authors:  David C S Roberts; Drake Morgan; Yu Liu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-28       Impact factor: 5.067

8.  Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats.

Authors:  Keri A Chiodo; Christopher M Läck; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

Review 9.  New developments in the pharmacotherapy of cocaine abuse.

Authors:  Antonio Preti
Journal:  Addict Biol       Date:  2007-06       Impact factor: 4.280

10.  The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.

Authors:  Lara A Ray; Jennifer L Krull; Lorenzo Leggio
Journal:  Front Psychiatry       Date:  2010-10-12       Impact factor: 4.157

View more
  8 in total

1.  The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine.

Authors:  Anushree N Karkhanis; Thomas J R Beveridge; Bruce E Blough; Sara R Jones; Mark J Ferris
Journal:  Drug Alcohol Depend       Date:  2016-06-25       Impact factor: 4.492

2.  Treatment of cocaine addiction with amphetamine, a sleep-suppressant drug: associative learning, sleep patterns and clinical perspectives.

Authors:  Laís F Berro; Roberto Frussa-Filho; Sergio Tufik; Monica L Andersen
Journal:  Psychopharmacology (Berl)       Date:  2013-12-04       Impact factor: 4.530

3.  The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats.

Authors:  Clayton T Bauer; Matthew L Banks; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

4.  Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat.

Authors:  Jeremiah W Bertz; Jianyong Chen; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

5.  A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration.

Authors:  Mark J Ferris; Erin S Calipari; Jamie H Rose; Cody A Siciliano; Haiguo Sun; Rong Chen; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2015-02-18       Impact factor: 7.853

6.  The pharmacokinetics of 3-fluoroamphetamine following delivery using clinically relevant routes of administration.

Authors:  Ying Jiang; Azizi Ray; Mohammad Shajid Ashraf Junaid; Sonalika Arup Bhattaccharjee; Kayla Kelley; Ajay K Banga; Bruce E Blough; Kevin S Murnane
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

7.  Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys.

Authors:  Joshua A Lile; Amy R Johnson; Matthew L Banks; Kevin W Hatton; Lon R Hays; Katherine L Nicholson; Justin L Poklis; Abner O Rayapati; Craig R Rush; William W Stoops; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2019-07-01       Impact factor: 3.157

8.  Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.

Authors:  Chloe J Jordan; Carley Lemay; Linda P Dwoskin; Kathleen M Kantak
Journal:  Psychopharmacology (Berl)       Date:  2016-09-06       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.